More articles from Airway pharmacology and treatment

Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study
Chantal Raherison-Semjen, Dave Singh, Huib A.M Kerstjens, Christian Gessner, Ana-Maria Tanase, David Lawrence, Abhijit Pethe, Karen Mezzi, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3389; DOI: 10.1183/13993003.congress-2021.PA3389
Use of health care and management of asthma patients in the emergency room during the COVID 19 pandemic: lessons for the next wave
Simon Foulquier, Elise Noel Savina, Laurent Guilleminault, Alain Didier, Frederic Balen

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3532; DOI: 10.1183/13993003.congress-2021.PA3532
Use of short-acting ß2-agonists in patients with adult-onset asthma during 12-years
Iida Vähätalo, Hannu Kankaanranta, Leena E Tuomisto, Onni Niemelä, Lauri Lehtimäki, Pinja Ilmarinen

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3395; DOI: 10.1183/13993003.congress-2021.PA3395
Mometasone/indacaterol demonstrates similar efficacy in men and women: pooled analyses of PALLADIUM and IRIDIUM studies
Christian Gessner, Richard Van Zyl-Smit, Dave Singh, Huib A.M. Kerstjens, Chantal Raherison-Semjen, David Lawrence, Abhijit Pethe, Ana-Maria Tanase, Karen Mezzi, Peter D'Andrea

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3388; DOI: 10.1183/13993003.congress-2021.PA3388
Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada
Karissa Johnston, Christina Qian, Mena Soliman, Stephen Noorduyn, Erika Penz

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2414; DOI: 10.1183/13993003.congress-2021.PA2414
Real-world treatment of incident COPD patients in Germany
Roland Buhl, Nils Picker, Marlene Hechtner, Anke Kondla, Patrick Hoffman, Ulf Maywald, Thomas Wilke, Claus F Vogelmeier

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2409; DOI: 10.1183/13993003.congress-2021.PA2409
No impact of statins on time to first COPD exacerbation or all-cause mortality
Nina Skalvan Godtfredsen, Mathias Weis Damkjær, Kjell Erik Julius Håkansson, Thomas Kallemose, Charlotte Suppli Ulrik

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2407; DOI: 10.1183/13993003.congress-2021.PA2407
Comparison of initial drug treatment of incident COPD patients with German treatment guidelines
Claus F Vogelmeier, Marlene Hechtner, Nils Picker, Angela Neitz, Patrick Hofmann, Ulf Maywald, Thomas Wilke, Roland Buhl

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2406; DOI: 10.1183/13993003.congress-2021.PA2406
REALizing and improving management of COPD in China: A prospective observational study
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Cheng Wang, Hongyan Shang, Yue Fei

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2404; DOI: 10.1183/13993003.congress-2021.PA2404
Investigating the drivers for COPD treatment decisions
António Jorge Ferreira, Per Bakke, Heikki Ekroos, Stéphane Soulard, Monika Haaksma-Herczegh, MONTSERRAT MESTRES-SIMON, Malena Águila-Fuentes, Janwillem Kocks, Onno C.P Van Schayck, Nikolaos Tzanakis, Didier Cataldo

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2413; DOI: 10.1183/13993003.congress-2021.PA2413

Main menu

User menu

Search

More articles from Airway pharmacology and treatment

Pages

Contact us